Myeloproliferative neoplasms and pregnancy
Subcutaneous rituximab versus intravenous rituximab – safety and efficacy results
Temsirolimus with BERT for the treatment of relapsed mantle cell and follicular lymphoma
Treating lymphoma beyond progression
iwAL 2018 day 2 discussion: novel approaches and targeted therapies in AML
Andrew Wei et al.